In CRC, M1 TAMs exert anti-cancer effects by secreting pro-inflammatory cytokines such as TNF-α and IL-1, and increased densities of M1 TAMs are linked with a favorable clinical outcome61. The gene discussed is TNF; the disease is cancer.